脂蛋白的关联 (a) 与严重的退行性大动脉狭窄症
Ah-Ram Kim1, Jung-Min Ahn1, Do-Yoon Kang1
1Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
JACC. Asia
|November 18, 2024
概括
升高的脂蛋白a (Lp[a]) 水平,特别是超过100 mg/dL,显著增加患严重退行性大动脉狭窄症的风险,并需要大动脉置换. 这些发现强调Lp[a]作为退行性AS进展的关键因素.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 临床医学 临床医学
背景情况:
- 脂蛋白a (Lp[a]) 是已知的动脉疾病的风险因素.
- 了解Lp[a]水平与退行性大动脉狭窄症 (AS) 之间的特定关联对于风险分层和管理至关重要.
研究的目的:
- 调查血清Lp(a) 水平与严重退行性AS发病率之间的关系.
- 评估Lp(a) 与随后主动脉替换 (AVR) 的需要之间的关联.
主要方法:
- 对44,742名患者进行了回顾性分析,这些患者的基线Lp(a) 测量和心声回声检测.
- 主要终点是严重退行性AS的发展 (最大心经外运速度≥4.0m/s).
- 调整的危险比率 (HRs) 被计算出来,以评估与不同Lp (a) 级别相关的风险.
主要成果:
- 较高的Lp(a) 水平与严重退行性AS的风险增加显著相关,调整后HR为1.96的水平>100 mg/dL (P=0.001).
- 血平>100 mg/dL也与较高的AVR风险显著相关 (调整HR:2.05;P=0.002).
- 没有发现Lp(a) 水平和严重的双或类风湿性AS之间存在显著的关联.
结论:
- 血清Lp (a) 含量超过100mg/dL是严重退行性AS和随后的AVR的重要独立预测因素.
- 这些发现强调了Lp (a) 在退行性AS的发病过程中的作用,独立于AS的基线严重程度.
- Lp (a) 可能作为一种有价值的生物标志物,用于识别患有严重退行性AS的高风险个体.
相关概念视频
01:15Aortic Regurgitation I: Introduction
3
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
3
01:22Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
01:23Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
01:27Mitral Valve Prolapse I: Introduction
4
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
01:38Inflammation
52.8K
Overview
52.8K